1 / 25

Tricyclic Antidepressant Cardiotoxicity: Beyond ABC to pH

Tricyclic Antidepressant Cardiotoxicity: Beyond ABC to pH. Andrew Dawson South Asian Clinical Toxicology Research Collaboration. The Case. A 70 kg man presents on 1-2 hours following a TCA overdose (3000 mg Amitryptilline) Unconscious Seizure BP 60 Systolic. TRICYCLIC ANTIDEPRESSANTS.

yeldell
Download Presentation

Tricyclic Antidepressant Cardiotoxicity: Beyond ABC to pH

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Tricyclic Antidepressant Cardiotoxicity:Beyond ABC to pH Andrew Dawson South Asian Clinical Toxicology Research Collaboration

  2. The Case • A 70 kg man presents on 1-2 hours following a TCA overdose (3000 mg Amitryptilline) • Unconscious • Seizure • BP 60 Systolic

  3. TRICYCLIC ANTIDEPRESSANTS • Revise the pharmacology and mechanisms • Relate this to the clinical picture • Advanced Treatment Options

  4. KINETICS • Highly lipid soluble weak bases • Rapidly absorbed • Anticholinergic effects may prolong absorption • High volume of distribution • Death and toxicity mainly before redistribution (toxic compartment) • Clinical Correlates • asymptomatic at 3 hours remain well • Liebelt EL, et al Ann Emerg Med 1995; 26(2):195-201 • >15 mg/kg associated major toxicity

  5. KINETICS • Protein binding > 95% • May saturate increasing free fraction • pH dependent • P450 Hepatic metabolism • Saturable: long elimination half life • Active metabolites • Clinical Correlates • Toxicity increase with acidosis • Prolonged clinical course

  6. Pharmacodynamically Promiscuous • Block re-uptake of noradrenaline and serotonin • Antagonists to H1 and H2 receptors,GABA • Alpha antagonists • Anticholinergic effects • Clinical Correlate • Anticholinergic effects • Hypotension

  7. Anticholinergic Syndrome • Anticholinergic Syndrome: • Hot as hell • Blind as a bat • Red as a beet • Dry as a bone • Mad as a hatter • A sensitive indicator for ingestion, but poor predictor for toxicity. • Full syndrome is rare

  8. CNS Toxicity • Anticholinergic psychosis • Coma • Myoclonus and seizures • Seizures are strongly associated with arrhythmia and acute deterioration and increased mortality • Lancet 1994;343:159-62 • J Tox - Clin Tox. 33(3):199-204, 1995

  9. Fast Sodium Channel blockers & pH • Slowing of the 0 phase of depolarisation • Rate dependent block • Ionized drug binds with the greatest affinity • Clinical Correlates • Increasing conduction defects • Impaired myocardial contractility

  10. Predicting Major Complication • QRS > 100 milliseconds or more in a limb lead is as good as TCA concentration • Ventricular arrhythmia • Sensitivity 0.79 (95% CI 0.58- 0.91) • Specificity 0.46 (95% CI 0.35- 0.59) • Seizures • Sensitivity 0.69 (95% CI 0.57- 0.78) • Specificity 0.69 (95% CI 0.58- 0.78) • Bailey et al J Tox ClinTox 2004 • RaVR > 3 mm • Sensitivity 0.81 • R/SaVR >.7 • Sensitivity 0.75

  11. CVS toxicity • Tachycardia: • Good indicator of TCA ingestion • Caused by cholinergic blockade • Catecholamine • Anxiety • Hypotension • Vasodilation, hypovolaemia, alpha receptor blockade • Serious myocardial depression (normally wide QRS) • Bradycardia: • generally associated major conduction block • severe toxicity

  12. HA H+ +A- • Drugs and Receptors can be considered to be weak acids or bases. • Equilibrium influenced by external pH • The balance of the equilibrium can be expressed by pKa • The pKa is the pH where [ionised] = [non-ionised]

  13. HA H+ +A- Henderson-Hasselbach • For basic compounds: • pH = pKa + log (non-ionised/ionised) • ionised/non-ionised = 10 (pKa – pH)

  14. TCA: pH = 7.1

  15. TCA: pH= 7.3 • 200 mEq bicarbonate

  16. TCA: pH =7.4 • 200 mEq bicarbonate

  17. pH: Local anesthetics Sodium Channel Blocker • Non-ionised form to diffuse • Preferential binding of ionised form in the channel • Narahashi T, Fraser DT. Site of action and active form of local anesthetics. Neurossci Res, 1971, 4, 65-99 • Demonstration pH sensitivity • pH 7.2 to 9.6 unblock the channel • Ritchie JM, Greengard P. On the mode of action of local anesthetics. Annu Rev Pharmacol. 1966, 6, 405-430

  18. TCA & pH • Sodium channel Binding • Ionisation trapping in the channel • Receptor preferentially binds ionised drug • Other mechanisms • Protein Binding • Phospholipid barrier • non-ionised diffusion = more rapid redistribution • Sodium Loading

  19. Protein Binding • Therapeutic concentrations • pH shift 7.1 to 7.5 • 95% to 96% protein binding • Toxic concentrations protein binding is saturated • pH change is effective in the absence of protein • Sasyniuk B ,Jhamandas V. J Pharmacol Exp Ther 1984;231:387-394 • Wang R,Schuyler J,Raymond R.The role of the cell membrane bicarbonate exchanger in NaHCO3 therapy of imipramine cardiac dysfunction J Toxicol Clin Toxicol 1997;35:533.

  20. pH or sodium • Sodium loading has an additive effect • Hypertonic saline (15meq/kg) > NaHCO3 > Hyperventilation • McCabe. Ann Emerg Med.1998;32:329-333. • Bicarbonate via cell membrane exchanger • block exchanger you lose the bicarbonate effect • Wang R,Schuyler J,Raymond R J Toxicol Clin Toxicol. 1997;35:533.

  21. Risk? • Shift oxygen desaturation curve • Cerebral blood flow & hypocapnoea • CBF varies linearly with PaCO2 ( 20 - 80 mmHg) • CBF change is 4% per mmHg PaCO2 • Sodium loading and hypertonicity

  22. Management CVS Toxicity • ABC • Avoid acidosis • Volume replacement often large • Ventilation to a low normal CO2 • Decontamination • Activated charcoal is indicated….mostly in the same patients who intubation is indicated

  23. Na Bicarbonate (AHA ACLS 2a) • Dose: Repeated 3-5 minutes • 1-3 meq/kg bolus (if not in shock) • 1-3 mls/kg of 8.4% solution • 3-6 meq bolus (if in shock) • Titrated by ECG • Monitored ABG target pH 7.55 -7.6

  24. ? Refractory Hypotension • Intropes with alpha effects: adrenaline • 3 Case reports of hypertonic saline • Cardiopulmonary bypass • Complex Ventricular Tachycardia • Consider Magnesium • Overdrive pacing

  25. Conclusion • Manipulation of pH alters the kinetics and dynamics of TCA • Recommendations are for bolus NaHCO3 • Resuscitation should not be ceased until the pH is corrected

More Related